The bone marrow niche, stem cells, and leukemia: Impact of drugs, chemicals, and the environment

Annals of the New York Academy of Sciences

Volumn 1310, Issue 1, 2014, Pages 7-31

  Greim, Helmut ^a   Kaden, Debra A ^b   Larson, Richard A ^c   Palermo, Christine M ^d   Rice, Jerry M ^e   Ross, David ^f   Snyder, Robert ^g  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ENVIRON INTERNATIONAL CORPORATION   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g RUTGERS UNIVERSITY   (United States)

Author keywords

Benzene; Bone marrow niche; Chemotherapeutic alkylating agents; Leukemia; Myelodysplastic syndrome; Stem cells; Topoisomerase II

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA INTERFERON; ANGIOPOIETIN 2; ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; BENZENE; CELL SURFACE PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); FOLLISTATIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; MICRORNA; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR RUNX1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALTERNATIVE RNA SPLICING; ANGIOGENESIS; APOPTOSIS; ARTICLE; BINDING SITE; BIOLUMINESCENCE; BLAST CELL CRISIS; BLAST TRANSFORMATION; BLEEDING; BLOOD CELL; BONE MARROW; BONE MARROW CELL; BONE MARROW NICHE; CANCER RISK; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL HOMING; CELL INTERACTION; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CELL TRACKING; CHROMOSOMAL INSTABILITY; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME BAND; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; COCULTURE; CYTOGENETICS; CYTOPENIA; DEMETHYLATION; DEREGULATION; DISEASE COURSE; DNA DAMAGE; DNA END JOINING REPAIR; DNA MODIFICATION; DNA REPAIR; DNA STRAND BREAKAGE; DORMANCY; DYSPLASIA; ENGRAFTMENT; ENVIRONMENTAL EXPOSURE; ERYTHROPOIESIS; FEEDBACK SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOMICS; GENOTYPE; GERM LINE; HAPLOINSUFFICIENCY; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HOMEOSTASIS; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; KARYOTYPE; LEUKEMIA; LEUKEMIA CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MACROCYTIC ANEMIA; MACROPHAGE; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MESENCHYME CELL; METABOLOMICS; METHYLATION; MICROARRAY ANALYSIS; MICROENVIRONMENT; MONOCYTE; MONOCYTOSIS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOID LEUKEMIA; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPROGENITOR CELL; OXIDATIVE STRESS; OXYGEN SUPPLY; PATHOGENESIS; PHAGOCYTOSIS; PHENOTYPE; PROTEOMICS; RADIATION EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; REGULATORY MECHANISM; RNA EDITING; RNA PROCESSING; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS; STEM CELL; STEM CELL NICHE; STROMA CELL; SUBCUTANEOUS FAT; TIME LAPSE IMAGING; TREATMENT RESPONSE; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VOLUME; UPREGULATION; WHOLE BODY RADIATION; WNT SIGNALING PATHWAY;

BENZENE; BONE MARROW NICHE; CHEMOTHERAPEUTIC ALKYLATING AGENTS; LEUKEMIA; MYELODYSPLASTIC SYNDROME; STEM CELLS; TOPOISOMERASE II;

ANIMALS; BONE MARROW CELLS; CELL TRANSFORMATION, NEOPLASTIC; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HUMANS; LABORATORY CHEMICALS; LEUKEMIA; MICE; SIGNAL TRANSDUCTION; STEM CELL NICHE;

EID: 84896260804     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12362     Document Type: Article

References (73)

1. Alberts, B. 2013. Designing scientific meetings. Science 339: 737.
2. Lo Celso, C. & D.T. Scadden. 2011. The haematopoietic stem cell niche at a glance. J. Cell Sci. 124: 3529-3535. doi:10.1242/jcs.074112.
3. Swerdlow, S.H., E. Campo, N.L. Harris, et al., Eds. 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer.
4. Irons, R.D., X. Wang, S.A. Gross, et al. 2006. Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications. Leuk. Res. 7: 769-775.
5. Santesson, C.G. 1897. Über chronische Vergiftungen mit Steinkohlenteerbenzin: vier Todesfälle. Arch. Hyg. Berlin 31: 336-376.
6. Aksoy, M., S. Erdem & G. DinÇol. 1974. Leukemia in shoe-workers exposed chronically to benzene. Blood 44: 837-841.
7. Infante, P.F., R.A Rinsky, J.K. Wagoner, et al. 1977. Leukemia in benzene workers. Lancet 9: 76-78.
8. Bond, J.A. & J.M. Rice, Eds. 2010. BENZENE 2009-health effects and mechanisms of bone marrow toxicity: implications for t-AML and the mode of action framework. Munich, Sept. 7-11, 2009. Chem. Biol. Interact. 184: 1-312.
9. Chan, C.K., P. Lindau, W. Jiang, et al. 2013. Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells. Proc. Natl. Acad. Sci. U. S. A. 110: 12643-12648.
10. Pang, W.W., J.V. Pluvinage, E.A. Price, et al. 2013. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc. Natl. Acad. Sci. U. S. A. 110: 3011-3016.
11. Willingham, S.B., J.P. Volkmer, A.J. Gentles, et al. 2012. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. U. S. A. 109: 6662-6667.
12. Chao, M.P., R. Majeti & I.L. Weissman. 2011. Programmed cell removal: a new obstacle in the road to developing cancer. Nat. Rev. Cancer 12: 58-67.
13. Jaiswal, S., C.H. Jamieson, W.W. Pang, et al. 2009. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138: 271-285.
14. Majeti, R., M.P. Chao, A.A. Alizadeh, et al. 2009. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138: 286-299.
15. Ehninger, A. & A. Trumpp. 2011. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 208: 421-428.
16. Schepers, K., E.M. Pietras, D. Reynaud, et al. 2013. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13: 285-299.
17. Reynaud, D., E. Pietras, K. Barry-Holson, et al. 2011. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 20: 661-673.
18. Crews, L.A. & C.H. Jamieson. 2013. Selective elimination of leukemia stem cells: hitting a moving target. Cancer Lett. 338: 15-22.
19. Crews, L.A. & C.H. Jamieson. 2013. "Molecular evolution of leukemia stem cells." In Stem Cells Handbook. S. Sell, Ed.: 449-458. New York: Springer Science+Business Media.
20. Li, L. & H. Clevers. 2010. Coexistence of quiescent and active adult stem cells in mammals. Science 327: 542-545.
21. Sugimura, R., X.C. He, A. Venkatraman, et al. 2012. Non-canonical Wnt signaling maintains hematopoietic stem cells through Flamingo and Frizzled8 in the niche. Cell 150: 351-365.
22. Raaijmakers, M.H., S. Mukherjee, S. Guo, et al. 2010. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464: 852-857.
23. Park, D., J.A. Spencer, B.I. Koh, et al. 2012. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10: 259-272.
24. Raynaud, C.M., J.M. Butler, N.M. Halabi, et al. 2013. Endothelial cells provide a niche for placental hematopoietic stem/progenitor cell expansion through broad transcriptomic modification. Stem Cell Res. 11: 1074-1090.
25. Renström, J., M. Kröger, C. Peschel, et al. 2010. How the niche regulates hematopoietic stem cells. Chem. Biol. Interact. 184: 7-15.
26. Renström, J., R. Istvanffy, K. Gauthier, et al. 2009. Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells. Cell Stem Cell 5: 157-167.
27. Istvanffy, R., M. Kröger, C. Eckl, et al. 2011. Stromal pleiotrophin regulates repopulation-behavior of hematopoetic stem cells. Blood 118: 2712-2722.
28. Casado, F.L., K.P. Singh & T.A. Gasiewicz. 2011. Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration. Mol. Pharmacol. 80: 673-682.
29. Essers, M.A., S. Offner, W.E. Blanco-Bose, et al. 2009. IFN alpha activates dormant haematopoietic stem cells in vivo. Nature 458: 904-908.
30. Storms, R.W., A.P. Trujillo, J.B. Springer, et al. 1999. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl. Acad. Sci. U. S. A. 96: 9118-9123.
31. Gasparetto, M., S. Sekulovic, C. Brocker, et al. 2012. Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development. Exp. Hematol. 40: 318-329.
32. Gasparetto, M., S. Sekulovic, A. Zakaryan, et al. 2012. Varying levels of aldehyde dehydrogenase activity in adult murine marrow hematopoietic stem cells are associated with engraftment and cell cycle status. Exp. Hematol. 40: 857-866.
33. Suda, T., K. Takubo & G.L. Semenza. 2011. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9: 298-310.
34. Hirabayashi, Y. & T. Inoue. 2012. "Prediction of epigenetic and stochastic gene expression profiles of late effects after radiation exposure." In Toxicology and Epigenetics. S.C. Sahu, Ed.: 475-510. Hoboken, NJ: John Wiley & Sons, Ltd.
35. Hirabayashi, Y. & T. Inoue. 2011. "Commonality and stochasticity in systems toxicology." In Handbook of Systems Toxicology. Vol. 1. D.A. Casciano & S.C. Sahu, Eds.: 432-460. Hoboken, NJ: John Wiley & Sons, Ltd.
36. Kobayashi, H., J.M. Butler, R. O'Donnell, et al. 2010. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 12: 1046-1056.
37. Caplan, A.I. & J.E. Dennis. 2006. Mesenchymal stem cells as trophic mediators. J. Cell Biochem. 98: 1076-1084.
38. Groen, R.W., W.A. Noort, R.A. Raymakers, et al. 2012. Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma. Blood 120: e9-e16. doi:10.1182/blood-2012-03-414920.
39. Goodell, M.A. & L.A. Godley. 2013. Perspectives and future directions for epigenetics in hematology. Blood 121: 5131-5137.
40. Gruber T.A., A. Larson Gedman, J. Zhang, et al. 2012. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell 22: 683-697. doi:10.1016/j.ccr.2012.10.007.
41. Hatlen M.A., L. Wang & S.D. Nimer. 2012. AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches. Front. Med. 6: 248-262. doi:10.1007/s11684-012-0206-6.
42. Abdel-Wahab, O. & R.L. Levine. 2013. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood 121: 3563-3572.
43. Metzeler, K.H., K. Maharry, J. Kohlschmidt, et al. 2013. A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia. Leukemia 27: 2023-2031.
44. McHale, C.M., L. Zhang & M.T. Smith. 2012. Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis 33: 240-252.
45. North, M. & C.D. Vulpe. 2010. Functional toxicogenomics: mechanism-centered toxicology. Int. J. Mol. Sci. 11: 4796-4813.
46. Irons, R.D., S.A Gross, A. Le, et al. 2010. Integrating WHO 2001-2008 criteria for the diagnosis of myelodysplastic syndrome (MDS): a case-case analysis of benzene exposure. Chem. Biol. Interact. 184: 30-38.
47. Irons, R.D., Y.Chen, X. Wang, et al. 2013. Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease. Genes Chromosomes Cancer 52: 887-894.
48. Wray, J., E.A. Williamson, S.B. Singh, et al. 2013. PARP1 is required for chromosomal translocations. Blood 121: 4359-4365.
49. Pedersen-Bjergaard, J., M.K. Andersen, M.T. Andersen, et al. 2008. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 22: 240-248.
50. Westman, M., J. Pedersen-Bjergaard, M.T. Andersen, et al. 2013. IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10). Leukemia 27: 957-959.
51. Joslin, J.M., A.A. Fernald, T.R. Tennant, et al. 2007. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 110: 719-726.
52. McClendon, A.K. & N. Osheroff. 2007. DNA topoisomerase II, genotoxicity, and cancer. Mutat. Res. 623: 83-97.
53. Churpek, J.E. & K. Onel. 2010. Heritability of hematologic malignancies: from pedigrees to genomics. Hematol. Oncol. Clin. North Am. 24: 939-972.
54. Knight, J.A., A.D. Skol, A. Shinde, et al. 2009. Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood 113: 5575-5582.
55. Best, T., D. Li, A.D. Skol, et al. 2011. Variants at 6Q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin lymphoma. Nat. Med. 17: 941-943.
56. Lassailly, F., K. Foster, L. Lopez-Onieva, et al. 2013. Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells. Blood 122: 1730-1740.
57. Ferrer, R.A., M. Wobus, C. List, et al. 2013. Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide. Haematologica 98: 1677-1685.
58. Sipkins, D.A., X. Wei, J.W. Wu, et al. 2005. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435: 969-973.
59. Colmone, A., M. Amorim & A.L. Pontier, et al. 2008. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322: 1861-1865.
60. Sipkins, D.A. 2009. Rendering the leukemia cell susceptible to attack. N. Engl. J. Med. 361: 1307-1309.
61. Shen, Y. & S.K. Nilsson. 2012. Bone, microenvironment and hematopoiesis. Cur. Opin. Hematol. 19: 250-255.
62. Grassinger, J., D.N. Haylock, B. Williams, et al. 2010. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biological potential. Blood 116: 3185-3196.
63. Ellis, S.L., J. Grassinger, A. Jones, et al. 2011. The relationship between bone, hemopoietic stem cells and vasculature. Blood 118: 1516-1524.
64. Wang, Q.F., G. Wu, S. Mi, et al. 2011. MLL fusion proteins preferentially regulate a subset of wild type MLL target genes in the leukemic genome. Blood 117: 6895-6905.
65. Go, Y.M. & D.P. Jones. 2013. The redox proteome. J. Biol. Chem. 288: 26512-26520.
66. Go, Y.M. & D.P. Jones. 2013. Thiol/disulfide redox states in signaling and sensing. Crit. Rev. Biochem. Mol. Biol. 48: 173-181.
67. Eilken, H.M., S. Nishikawa & T. Schroeder. 2009. Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature 457: 896-900.
68. Coutu, D.L. & T. Schroeder. 2013. Probing cellular processes by long-term live imaging-historic problems and current solutions. J. Cell Sci. 126: 3805-3815.
69. Schroeder, T. 2011. Long-term single-cell imaging of mammalian stem cells. Nat. Methods 8(Suppl.): S30-S35.
70. Wild, C.P. 2012. The exposome: from concept to utility. Int. J. Epidemiol. 41: 24-32.
71. Rappaport, S.M. & M.T. Smith. 2010. Epidemiology. Environment and disease risks. Science 330: 460-461.
72. Smith, M.T., L. Zhang, C.M. McHale, et al. 2011. Benzene, the exposome and future investigations of leukemia etiology. Chem. Biol. Interact. 192: 155-159.
73. Patel, J. et al. 2012. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N. Engl. J. Med. 366: 1079-1089.